2.2. Participants
bleeding, allergy
BLEEDING, ALLERGY, DYSLIPIDEMIA
Consecutive patients who were admitted to Yokosuka City Hospital between July and November 2015 were recruited. The study was approved by the ethics committee of Yokosuka City Hospital and registered at the University Hospital Medical Information Network (UMIN000017853). All participants provided written informed consent prior to the study enrollment. The inclusion criteria were as follows: patients (1) who underwent hemodialysis with a diagnosis of dyslipidemia, (2) who were aged ≥ 20 years, (3) who did not receive omega-3 fatty acids (including supplements) in the last 6 months, and (4) who provided voluntary informed consent after receiving a full explanation of the study’s purpose and methods. In contrast, the exclusion criteria were as follows: patients (1) with a history of allergy to omega-3 fatty acids, (2) with confirmed or suspected pregnancy, (3) with active bleeding, and (4) who were removed from the study for any reason at the investigators’ discretion.